Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 1930598, 10 pages
https://doi.org/10.1155/2017/1930598
Research Article

Molecular Targets and Associated Potential Pathways of Danlu Capsules in Hyperplasia of Mammary Glands Based on Systems Pharmacology

1Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong
3Suzhong Pharmaceutical Group Co., Ltd., Taizhou 225500, China

Correspondence should be addressed to Kun Wang and Qingshan Zheng

Received 4 January 2017; Revised 31 March 2017; Accepted 23 April 2017; Published 23 May 2017

Academic Editor: Olumayokun A. Olajide

Copyright © 2017 Jihan Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L.-J. Zhang, A.-F. Song, Z.-H. Wang, and Y. Lu, “Effects of the needling method for regulating kidney and smoothing liver on endocrine and immune functions in the patient with hyperplasia of mammary glands,” Chinese Acupuncture & Moxibustion, vol. 28, no. 9, pp. 648–652, 2008. View at Google Scholar · View at Scopus
  2. E. J. Golsteyn and M. J. Fritzler, “The role of the thymus-hypothalamus-pituitary-gonadal axis in normal immune processes and autoimmunity,” Journal of Rheumatology, vol. 14, no. 5, pp. 982–990, 1987. View at Google Scholar · View at Scopus
  3. Y. Fan, X. Pei, Z. Liu et al., “Effectiveness of external Sanjierupi Gao on mastalgia caused by mammary gland hyperplasia: a placebo controlled trial,” Journal of Traditional Chinese Medicine, vol. 33, no. 5, pp. 603–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. N. L. Henry, “Endocrine therapy toxicity: management options,” American Society of Clinical Oncology Educational Book, vol. 34, pp. e25–e30, 2014. View at Publisher · View at Google Scholar
  5. L.-Q. Qian, X.-H. Pei, Z.-Y. Xu, and C. Wang, “Clinical observation on treatment of hyperplasia of mammary gland by Lirukang Granule,” Chinese Journal of Integrative Medicine, vol. 13, no. 2, pp. 120–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Jia, X. Liu, Q. Jia et al., “The anti-hyperplasia of mammary gland effect of protein extract HSS from Tegillarca granosa,” Biomedicine & Pharmacotherapy, vol. 85, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  7. Y. R. Wang, Y. H. Zhu, Z. Y. Xu et al., “Pathological evaluation of experimental mammary gland hyperplasia treated with kerutong capsule,” Journal of Nanjing University of Traditional Chinese Medicine, vol. 16, no. 2, pp. 98-99.
  8. W. H. Bian, Z. Y. Xu, and C. Yao, “Clinical research on kerutong capsules for treatment hyperplasia of mammary glands,” Chinese Journal of Surgery of Integrated Traditional and Western Medicine, vol. 7, no. 6, pp. 380-381.
  9. D. Liu, Y. He, and Q. XiaO, “Clinical observation on kerutong capsules for treatment of hyperplasia of mammary glands,” Hubei College of Traditional Chinese Medicine, vol. 27, no. 9, pp. 19-20.
  10. Y.-M. Ma, X.-Z. Zhang, Z.-Z. Su et al., “Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro,” Journal of Ethnopharmacology, vol. 173, pp. 91–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. I. Berger, A. Ma'ayan, and R. Iyengar, “Systems pharmacology of arrhythmias,” Science Signaling, vol. 3, no. 118, p. ra30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Hopkins, “Network pharmacology,” Nature Biotechnology, vol. 25, no. 10, pp. 1110-1111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Ru, P. Li, J. Wang et al., “TCMSP: a database of systems pharmacology for drug discovery from herbal medicines,” Journal of Cheminformatics, vol. 6, no. 1, p. 13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Xu, W. Zhang, C. Huang et al., “A novel chemometric method for the prediction of human oral bioavailability,” International Journal of Molecular Sciences, vol. 13, no. 6, pp. 6964–6982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Tao, X. Xu, X. Wang et al., “Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yamanishi, M. Kotera, M. Kanehisa, and S. Goto, “Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework,” Bioinformatics, vol. 26, no. 12, Article ID btq176, pp. i246–i254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Smoot, K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431-432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. F. Wu, H. Q. Li, L. J. Jin et al., “Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry and pharmacology,” Journal of Ethnopharmacology, vol. 145, no. 2, pp. 403–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Chunmei, L. Xiaoyu, and Y. Zuguang, “Review on chemical composition, pharmacological activity and application of marine traditional chinese medicine oyster,” Natural Product Research and Development, vol. 28, pp. 471–474, 2016. View at Google Scholar
  20. B. Kaminska, “MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1754, no. 1-2, pp. 253–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Chen, J. Li, J. Chen, H. Song, and C. Yang, “Anti-hyperplasia effects of Rosa rugosa polyphenols in rats with hyperplasia of mammary gland,” Environmental Toxicology and Pharmacology, vol. 39, no. 2, pp. 990–996, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. X.-L. Liu, C. Lv, and W.-S. Zhang, “Advance in studies on TRPV1 and analgesic effect oftraditional Chinese medicines,” Zhongguo Zhong Yao Za Zhi, vol. 39, no. 10, pp. 1757–1760, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Maeda and M. Ozaki, “Study on novel mechanism underlying analgesia targeting TRPV1,” Yakugaku Zasshi, vol. 134, no. 3, pp. 373–378, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-D. Brederson, P. R. Kym, and A. Szallasi, “Targeting TRP channels for pain relief,” European Journal of Pharmacology, vol. 716, no. 1–3, pp. 61–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. D. P. Mohapatra and C. Nau, “Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase,” Journal of Biological Chemistry, vol. 280, no. 14, pp. 13424–13432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Lin, Y.-W. Qiu, G.-Y. He, and N. Guan, “Effects of litchi chinensis seed saponins on inhibiting hyperplasia of mammary glands and influence on signaling pathway of estrogen in rats,” Journal of Chinese Medicinal Materials, vol. 38, no. 4, pp. 798–802, 2015. View at Google Scholar · View at Scopus
  27. M. Marino, P. Galluzzo, and P. Ascenzi, “Estrogen signaling multiple pathways to impact gene transcription,” Current Genomics, vol. 7, no. 8, pp. 497–508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Matthews and J.-A. Gustafsson, “Estrogen signaling: a subtle balance between ER alpha and ER beta,” Molecular Interventions, vol. 3, no. 5, pp. 281–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Wang, X. Fan, H. Qu, X. Gao, and Y. Cheng, “Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine,” Current Topics in Medicinal Chemistry, vol. 12, no. 12, pp. 1356–1362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-Q. Cai, X. Wang, M.-Y. Shang, F. Xu, and G.-X. Liu, “"Efficacy theory" may help to explain characteristic advantages of traditional Chinese medicines,” Zhongguo Zhong Yao Za Zhi, vol. 40, no. 17, pp. 3435–3443, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Y. Li, J. An, S. J. Jones, and P. E. Bourne, “A computational approach to finding novel targets for existing drugs,” PLoS Computational Biology, vol. 7, no. 9, p. e1002139, 2011. View at Publisher · View at Google Scholar
  32. L. J. Liu, H. L. Du, Y. C. Jin, and J. W. Chen, “Effects of combined acupuncture and medicine therapy on the breast tissue and expressions of estrogen receptor subgroups in the rat of hyperplasia of mammary glands,” Zhongguo Zhen Jiu, vol. 27, no. 4, pp. 279–283.
  33. M. Gilca, I. Stoian, and L. Gaman, “A new insight into estrogen signaling: Yin-yang perspective,” Journal of Alternative and Complementary Medicine, vol. 19, no. 1, pp. 63–68, 2013. View at Publisher · View at Google Scholar · View at Scopus